Fulgent Genetics Inc (OQ:FLGT)

Business Focus: Medical & Diagnostic Laboratories

Nov 14, 2023 04:30 pm ET
Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that members of its management team are scheduled to participate in the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023.
Nov 03, 2023 04:05 pm ET
Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced data from two poster presentations being presented tomorrow, November 4, 2023, at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting in San Diego, CA.
Nov 03, 2023 07:00 am ET
Fulgent Reports Third Quarter 2023 Financial Results
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced financial results for its third quarter ended September 30, 2023.
Oct 25, 2023 08:00 am ET
Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced two upcoming poster presentations at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting, to be held virtually and at the San Diego Convention Center from November 1 to 5, 2023.
Oct 17, 2023 08:00 am ET
Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that it will release its third quarter 2023 financial results before the market opens on Friday, November 3, 2023. Management will host a conference call for the investment community the same day at 8:30 AM ET (5:30 AM PT) to discuss the results and answer questions.
Aug 04, 2023 07:00 am ET
Fulgent Reports Second Quarter 2023 Financial Results
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced financial results for its second quarter ended June 30, 2023.
Jul 24, 2023 04:05 pm ET
Exagen Inc. Appoints Paul Kim to Board of Directors
Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Paul Kim has been appointed as a member of the Exagen Board of Directors, effective July 24, 2023. Mr. Kim currently serves as Chief Financial...
Jul 18, 2023 08:00 am ET
Fulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that it will release its second quarter 2023 financial results before the market opens on Friday, August 4, 2023. Management will host a conference call for the investment community the same day at 8:30 AM ET (5:30 AM PT) to discuss the results and answer questions.
Jun 05, 2023 08:30 am ET
Fulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various Cancers
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced data from a Phase 1/1b clinical study of FID-007 in treating various solid tumors was presented in a poster session at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, IL on June 3, 2023.
May 18, 2023 04:05 pm ET
Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2023 Annual Meeting
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that Phase 1/1b clinical data on its lead therapeutic development candidate, FID-007, to treat various solid tumors, will be presented at the American Society for Clinical Oncology (ASCO) Annual Meeting at 8:00 a.m. Central Time on June 3, 2023 in Chicago, Illinois.
May 05, 2023 07:00 am ET
Fulgent Reports First Quarter 2023 Financial Results
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced financial results for its first quarter ended March 31, 2023.
Apr 20, 2023 04:05 pm ET
Fulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that it will release its first quarter 2023 financial results before the market opens on Friday, May 5, 2023. Management will host a conference call for the investment community the same day at 8:30 AM ET (5:30 AM PT) to discuss the results and answer questions.
Apr 11, 2023 08:00 am ET
Mission Bio Partners with Fulgent Genetics to Broaden Accessibility of Single-Cell Multi-Omics for Drug Development and Clinical Research
Strategic partnership between Mission Bio and Fulgent Genetics will enable drug developers to leverage single-cell multi-omics for biomarker discovery, clinical research, and single-cell MRD development at scale
Feb 28, 2023 04:05 pm ET
Fulgent Reports Fourth Quarter and Full Year 2022 Financial Results
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”, or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced financial results for its fourth quarter and full year ended December 31, 2022.
Feb 28, 2023 04:03 pm ET
Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced the immediate availability of their new Beacon787 expanded carrier screening panel. Beacon787 will include a total of 787 genes associated with autosomal recessive and X-linked conditions. Included in this panel are all of the American College of Medical Genetics and Genomics (ACMG) tier 3 genes, which ACMG published in their latest practice guideline for carrier screening, recommending that a
Feb 23, 2023 04:05 pm ET
Fulgent to Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference
Fulgent, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that members of its management team are scheduled to participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference on Tuesday, March 7, 2023.
Feb 14, 2023 04:05 pm ET
Fulgent Genetics to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing and therapeutics company focused on transforming patient care in oncology, infectious and rare diseases, reproductive health, and pathology, today announced that it will release its fourth quarter and full year 2022 financial results after the market closes on Tuesday, February 28, 2023. Management will host a conference call for the investment community the same day at 4:30 PM ET (1:30 PM PT) to discuss the results and answer questions.
Jan 18, 2023 12:23 pm ET
CONTINUED INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors of its continued investigation of certain directors and officers of Fulgent Genetics, Inc. (“Fulgent”) (NASDAQ:...
Jan 13, 2023 09:00 pm ET
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (NASDAQ: FLGT) on behalf of long-term stockholders following a class action complaint that was filed...
Jan 10, 2023 08:00 am ET
INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors of its continued investigation of certain directors and officers of Fulgent Genetics, Inc. (“Fulgent”) (NASDAQ: FLGT) for breaching their fiduciary duties to
Jan 03, 2023 04:05 pm ET
Fulgent Expands Board of Directors with Addition of Reggie Groves
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics”, “Fulgent” or the “company”) today announced the addition of Reggie Groves to its board of directors, effective January 3, 2023.
Dec 27, 2022 09:30 am ET
Barrack, Rodos & Bacine (BR&B) Is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) For Potential Investor Claims
Barrack, Rodos & Bacine (BR&B) is investigating Fulgent Genetics Inc. based on issues arising from its recent acquisitions, including the acquisition of Fulgent Pharma LLC, a wholly owned subsidiary of Fulgent Pharma Holdings, which itself is...
Dec 08, 2022 09:02 am ET
Investigation Alert PYPL, FLGT, OLO, KSS: Johnson Fistel, LLP Encourages Long-Term Investors to Contact the Firm; Should Management be Held Accountable for Investors’ Losses?
PayPal Holdings, Inc. (NASDAQ: PYPL) Johnson Fistel, LLP is investigating potential claims on behalf of PayPal Holdings, Inc. (NASDAQ: PYPL) (“PayPal” or the “Company”) against certain of its officers and directors. If you are a current,...
Nov 28, 2022 02:56 pm ET
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating certain directors and officers of Fulgent Genetics, Inc. (“Fulgent”) (NASDAQ: FLGT) for breaching their fiduciary duties to Fulgent and its shareholders. If
Nov 21, 2022 02:30 pm ET
FINAL DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 21, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nov 21, 2022 11:45 am ET
DEADLINE ALERT for FLGT, YSG, BCS, and OLO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Nov 21, 2022 11:00 am ET
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, Nov. 21, 2022 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ: FLGT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nov 21, 2022 04:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fulgent Investors of a Lead Plaintiff Deadline of November 21, 2022
NEW YORK, Nov. 21, 2022 /PRNewswire/ -- Attention Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT) shareholders:
Nov 20, 2022 11:15 pm ET
24-Hour Deadline Alert: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. With Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 20, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nov 20, 2022 06:01 pm ET
Final Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed against Fulgent Genetics, Inc. (FLGT)
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Fulgent Genetics, Inc....
Nov 19, 2022 10:59 am ET
FLGT 2-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact the Firm’s Attorneys Before Nov. 21st Deadline in Se
Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now. A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations....
Nov 18, 2022 05:30 pm ET
DEADLINE MONDAY NOTICE: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 18, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nov 18, 2022 05:17 pm ET
FLGT DEADLINE ALERT: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action – FLGT
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, both dates inclusive (the “Class Period”), of the important November...
Nov 18, 2022 05:00 pm ET
72-Hour Deadline Alert: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 18, 2022 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nov 18, 2022 02:07 pm ET
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)
The Law Offices of Frank R. Cruz reminds investors of the upcoming November 21, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ:
Nov 18, 2022 12:05 pm ET
Fulgent Genetics, Inc. Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Important Lead Plaintiff Deadline on November 21, 2022 in Securities Fraud Class Action Lawsuit
RADNOR, Pa., Nov. 18, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT). The action charges Fulgent with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects.  As a result of Fulgent's materially misleading statements and omissions to the public, Fulgent investors have suffered significant losses.
Nov 18, 2022 04:45 am ET
FLGT SHAREHOLDER ALERT: Jakubowitz Law Reminds Fulgent Shareholders of a Lead Plaintiff Deadline of November 21, 2022
NEW YORK, Nov. 18, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Fulgent Genetics, Inc. (NASDAQ: FLGT).
Nov 17, 2022 07:08 pm ET
Lifshitz Law PLLC Announces Investigations of Kohls Corporation (NYSE: KSS), Sema4 Holdings Corporation (NASDAQ: SMFR), Palantir Technologies, Inc. (NYSE: PLTR), and Fulgent Genetics, Inc. (NASDAQ: FL
Kohls Corporation (NYSE: KSS) Lifshitz Law PLLC announces that a class action complaint was filed on behalf of shareholders of Kohls alleging that Defendants made materially false and misleading statements regarding the Company’s business,...
Nov 17, 2022 04:05 pm ET
Fulgent Genetics to Participate in Piper Sandler’s 34th Annual Healthcare Conference
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing and therapeutics company focused on transforming patient care in oncology, infectious and rare diseases, reproductive health, and pathology, today announced that members of its management team are scheduled to participate in the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022.
Nov 17, 2022 01:30 pm ET
4-Day Deadline Alert: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 17, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nov 17, 2022 11:00 am ET
FLGT Investors Have Opportunity to Lead Fulgent Genetics, Inc. Securities Fraud Lawsuit
LOS ANGELES, Nov. 17, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT).
Nov 17, 2022 04:45 am ET
FLGT LAWSUIT ALERT: Levi & Korsinsky Notifies Fulgent Genetics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Nov. 17, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT) of a class action securities lawsuit.
Nov 16, 2022 08:40 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulgent, Yatsen, Barclays, and Warner Bros. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Fulgent Genetics, Inc. (NASDAQ: FLGT), Yatsen Holding Ltd. (NYSE: YSG), Barclays...
Nov 16, 2022 06:30 pm ET
MONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 16, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nov 16, 2022 11:00 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming November 21, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fulgent Genetics, Inc. (“Fulgent”...
Nov 16, 2022 04:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fulgent Genetics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2022 - (NASDAQ: FLGT)
NEW YORK, Nov. 16, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fulgent Genetics, Inc.
Nov 15, 2022 11:45 am ET
DEADLINE ALERT for FLGT, YSG, BCS, and OLO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Nov 15, 2022 11:00 am ET
Deadline Alert: Fulgent Genetics, Inc. (FLGT) - Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Class Action Deadlines and Encourages Shareholders to Contact the Firm and A
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Fulgent securities between March 22, 2019 and August 4, 2022, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site:
Nov 15, 2022 04:45 am ET
FLGT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 21, 2022 in the Class Action Filed on Behalf of Fulgent Genetics, Inc. Shareholders
NEW YORK, Nov. 15, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Fulgent Genetics, Inc. (NASDAQ: FLGT) alleging that the Company violated federal securities laws.
Nov 15, 2022 01:45 am ET
FULGENT GENETICS, INC. (NASDAQ: FLGT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Agai
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Nov 14, 2022 11:57 am ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact Firm’s Attorneys Before Nov. 21st Deadline in Securities Class Action
Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now. A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations....
Nov 14, 2022 11:00 am ET
DEADLINE ALERT for FLGT, YSG, BCS, OLO: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Nov 14, 2022 04:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fulgent Investors of a Lead Plaintiff Deadline of November 21, 2022
NEW YORK, Nov. 14, 2022 /PRNewswire/ -- Attention Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT) shareholders:
Nov 13, 2022 10:43 am ET
DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Fulgent Genetics, Inc. Securities Fraud Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Fulgent Genetics, Inc....
Nov 11, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Palantir Technologies, Inc. (NYSE: PLTR), Fulgent Genetics, Inc. (NASDAQ: FLGT),...
Nov 11, 2022 12:41 pm ET
ROSEN, A TOP RANKED LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important November 21 Deadline in Securities Class Action – FLGT
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, both dates inclusive (the “Class Period”), of the important November...
Nov 11, 2022 12:00 pm ET
FLGT Investors Have Opportunity to Lead Fulgent Genetics, Inc. Securities Fraud Lawsuit
LOS ANGELES, Nov. 11, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT).
Nov 11, 2022 10:35 am ET
PLTR, FLGT & WBD Class Action Deadlines: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Nov 11, 2022 04:45 am ET
FLGT SHAREHOLDER ALERT: Jakubowitz Law Reminds Fulgent Shareholders of a Lead Plaintiff Deadline of November 21, 2022
NEW YORK, Nov. 11, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Fulgent Genetics, Inc. (NASDAQ: FLGT).
Nov 10, 2022 07:00 pm ET
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 10, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nov 10, 2022 04:45 am ET
FLGT LAWSUIT ALERT: Levi & Korsinsky Notifies Fulgent Genetics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Nov. 10, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT) of a class action securities lawsuit.
Nov 09, 2022 06:27 pm ET
Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed against Fulgent Genetics, Inc.
RADNOR, Pa., Nov. 9, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT). The action charges Fulgent with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Fulgent's materially misleading statements and omissions to the public, Fulgent investors have suffered significant losses.
Nov 09, 2022 03:20 pm ET
NOVEMBER DEADLINE ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. With Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 9, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nov 09, 2022 11:35 am ET
Fulgent Genetics’s Investor Alert: Kaplan Fox Reminds Investors of an Important Deadline
Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a securities class action case has been brought against Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) and that November 21, 2022 is the deadline for seeking...
Nov 09, 2022 04:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fulgent Genetics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2022 - (NASDAQ: FLGT)
NEW YORK, Nov. 9, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fulgent Genetics, Inc..
Nov 08, 2022 05:49 pm ET
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That Securities Class Action Lawsuits Have Been Filed on Behalf of Investors in Argo Group International Holdings, Ltd. (ARGO), Fulgent Genetics,
The law firm of Kirby McInerney LLP reminds investors that securities class action lawsuits have been filed on behalf of investors in securities of Argo Group International Holdings, Ltd., Fulgent Genetics, Inc., and Olo Inc. Investors have until...
Nov 08, 2022 12:00 pm ET
DEADLINE ALERT for FLGT, YSG, BCS, OLO: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Nov 08, 2022 08:30 am ET
SHAREHOLDER ALERT: Fulgent Genetics (FLGT) Officers and Directors Under Investigation for Possible False Statements About Its Business Operations and Compliance Policies
SAN FRANCISCO, Nov. 8, 2022 /PRNewswire/ -- ASchubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Fulgent Genetics (NASDAQ: FLGT) relating to possible false and misleading statements to investors about the company's business operations and compliance policies. 
Nov 08, 2022 04:45 am ET
FLGT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 21, 2022 in the Class Action Filed on Behalf of Fulgent Genetics, Inc. Shareholders
NEW YORK, Nov. 8, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Fulgent Genetics, Inc. (NASDAQ: FLGT) alleging that the Company violated federal securities laws.
Nov 08, 2022 01:45 am ET
FULGENT GENETICS, INC. (NASDAQ: FLGT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Agai
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Nov 07, 2022 05:26 pm ET
Fulgent Class Action Complaint Filed: Johnson Fistel Encourages Shareholders Who Held FLGT During the Stock Drop to Contact the Firm
Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT). The class action is on behalf of shareholders who...
Nov 07, 2022 04:06 pm ET
Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company
Fulgent Genetics, Inc. (NASDAQ: FLGT), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, announced today that it has completed an acquisition of Fulgent Pharma Holdings, Inc. (“Fulgent Pharma”), an independent clinical-stage, therapeutics development company focused on the development of innovative cancer treatments. Under the terms of the agreement, Fulgent Genetics acquired Fulgent Pharma for a total purchase price of approximately $100 million, subject to adjustments, to be paid with a combinat
Nov 07, 2022 04:05 pm ET
Fulgent Genetics Reports Third Quarter 2022 Financial Results
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics”, “Fulgent”, or the “Company”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced financial results for its third quarter ended September 30, 2022.
Nov 07, 2022 11:45 am ET
DEADLINE ALERT for FLGT, YSG, BCS, and OLO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Nov 07, 2022 11:00 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming November 21, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fulgent Genetics, Inc. (“Fulgent”...
Nov 07, 2022 09:05 am ET
FLGT 2-WEEK DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact the Firm’s Attorneys, Securities Class Action Pendi
Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now. A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations....
Nov 07, 2022 04:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fulgent Investors of a Lead Plaintiff Deadline of November 21, 2022
NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Attention Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT) shareholders:
Nov 06, 2022 10:45 pm ET
SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. With Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 6, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nov 06, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulgent, Yatsen, Barclays, and Warner Bros. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Fulgent Genetics, Inc. (NASDAQ: FLGT), Yatsen Holding Ltd. (NYSE: YSG), Barclays...
Nov 06, 2022 02:42 pm ET
ROSEN, A TOP RANKED FIRM, Encourages Fulgent Genetics, Inc. Investors With Losses to Secure Counsel Before Important November 21 Deadline in Securities Class Action – FLGT
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, both dates inclusive (the “Class Period”), of the important November...
Nov 05, 2022 02:53 pm ET
Kessler Topaz Meltzer & Check, LLP Reminds Investors of November 21, 2022 Deadline in Securities Fraud Class Action against Fulgent Genetics, Inc. Investors and Urges Investors with Substantial Losses
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Fulgent Genetics, Inc....
Nov 04, 2022 10:50 pm ET
FULGENT GENETICS SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent Genetics, Inc. - FLGT
NEW ORLEANS, Nov. 4, 2022 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 21, 2022 to file lead plaintiff applications in a securities class action lawsuit against Fulgent Genetics, Inc. (NasdaqGM: FLGT), if they purchased the Company's securities between March 22, 2019 and August 4, 2022, inclusive (the "Class Period").  This action is pending in the United States District Court for the Central District of California.
Nov 04, 2022 04:15 pm ET
NOVEMBER DEADLINE ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. With Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 4, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nov 04, 2022 11:47 am ET
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That Securities Class Action Lawsuits Have Been Filed on Behalf of Investors in Argo Group International Holdings, Ltd. (ARGO), Fulgent Genetics,
The law firm of Kirby McInerney LLP reminds investors that securities class action lawsuits have been filed on behalf of investors in securities of Argo Group International Holdings, Ltd., Fulgent Genetics, Inc., and Olo Inc. Investors have until...
Nov 04, 2022 05:45 am ET
FLGT SHAREHOLDER ALERT: Jakubowitz Law Reminds Fulgent Shareholders of a Lead Plaintiff Deadline of November 21, 2022
NEW YORK, Nov. 4, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Fulgent Genetics, Inc. (NASDAQ: FLGT).
Nov 03, 2022 07:00 pm ET
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. With Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 3, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nov 03, 2022 12:00 pm ET
FLGT Investors Have Opportunity to Lead Fulgent Genetics, Inc. Securities Fraud Lawsuit
BENSALEM, Pa., Nov. 3, 2022 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT).
Nov 03, 2022 05:45 am ET
FLGT LAWSUIT ALERT: Levi & Korsinsky Notifies Fulgent Genetics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Nov. 3, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT) of a class action securities lawsuit.
Nov 02, 2022 10:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Fulgent Genetics, Inc. - FLGT
CEDARHURST, N.Y., Nov. 2, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Fulgent Genetics, Inc. (NasdaqGM: FLGT), if they purchased the Company's securities between March 22, 2019 and August 4, 2022, inclusive (the "Class Period"). Shareholders have until November 21, 2022 to file lead plaintiff applications in the securities class action lawsuit.
Nov 02, 2022 06:30 pm ET
IMPORTANT NOVEMBER DEADLINE: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. With Losses of $250,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 2, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nov 02, 2022 12:07 pm ET
DEADLINE ALERT for FLGT, YSG, BCS, and OLO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Nov 02, 2022 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fulgent Genetics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2022 - (NASDAQ: FLGT)
NEW YORK, Nov. 2, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fulgent Genetics, Inc..
Nov 01, 2022 10:53 pm ET
FULGENT GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit A
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 21, 2022 to file lead plaintiff applications in a securities class action lawsuit against...
Nov 01, 2022 05:34 pm ET
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – FLGT
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, both dates inclusive (the “Class Period”), of the important November...
Nov 01, 2022 04:00 pm ET
FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. With Losses of $250,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 1, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nov 01, 2022 01:00 pm ET
DEADLINE ALERT for FLGT, YSG, BCS, OLO: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Nov 01, 2022 12:30 pm ET
FULGENT GENETICS, INC. (NASDAQ: FLGT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Agai
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Nov 01, 2022 10:34 am ET
PLTR, FLGT & WBD Class Action Deadlines: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Nov 01, 2022 05:45 am ET
FLGT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 21, 2022 in the Class Action Filed on Behalf of Fulgent Genetics, Inc. Shareholders
NEW YORK, Nov. 1, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Fulgent Genetics, Inc. (NASDAQ: FLGT) alleging that the Company violated federal securities laws.
Oct 31, 2022 09:13 pm ET
FLGT CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Fulgent Genetics, Inc. Shareholders of Securities Fraud Class Action Lawsuit
RADNOR, Pa., Oct. 31, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT). The action charges Fulgent with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Fulgent's materially misleading statements and omissions to the public, Fulgent investors have suffered significant losses.
Oct 31, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Palantir Technologies, Inc. (NYSE: PLTR), Fulgent Genetics, Inc. (NASDAQ: FLGT),...
Oct 31, 2022 12:00 pm ET
FLGT Investors Have Opportunity to Lead Fulgent Genetics, Inc. Securities Fraud Lawsuit
LOS ANGELES, Oct. 31, 2022 /PRNewswire/ --The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT).
Oct 31, 2022 09:54 am ET
FLGT SHAREHOLDER NOTICE: Hagens Berman, National Trial Attorneys, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact Firm’s Attorneys Before Nov. Deadline in Securities Cl
Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now. A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations....
Oct 31, 2022 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fulgent Investors of a Lead Plaintiff Deadline of November 21, 2022
NEW YORK, Oct. 31, 2022 /PRNewswire/ -- Attention Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT) shareholders:
Oct 30, 2022 03:58 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulgent Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline – FLGT
Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) and certain of its officers. The class action, filed in the United States District Court for the Central...
Oct 28, 2022 10:50 pm ET
FULGENT GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit A
NEW ORLEANS, Oct. 28, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 21, 2022 to file lead plaintiff applications in a securities class action lawsuit against Fulgent Genetics, Inc. (NasdaqGM: FLGT), if they purchased the Company's securities between March 22, 2019 and August 4, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the Central District of California.
Oct 28, 2022 03:50 pm ET
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLGT
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, both dates inclusive (the “Class Period”), of the important November...
Oct 28, 2022 01:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming November 21, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fulgent Genetics, Inc. (“Fulgent”...
Oct 28, 2022 05:45 am ET
FLGT SHAREHOLDER ALERT: Jakubowitz Law Reminds Fulgent Shareholders of a Lead Plaintiff Deadline of November 21, 2022
NEW YORK, Oct. 28, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Fulgent Genetics, Inc. (NASDAQ: FLGT).
Oct 27, 2022 11:45 am ET
DEADLINE ALERT for FLGT, YSG, BCS, and OLO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 27, 2022 08:50 am ET
FULGENT DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Fulgent Genetics, Inc. of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Fulgent Genetics, Inc....
Oct 27, 2022 05:45 am ET
FLGT LAWSUIT ALERT: Levi & Korsinsky Notifies Fulgent Genetics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Oct. 27, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT) of a class action securities lawsuit.
Oct 26, 2022 10:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Fulgent Genetics, Inc. - FLGT
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Fulgent Genetics, Inc. (NasdaqGM: FLGT), if they purchased the Company’s securities between March 22, 2019 and August 4, 2022, inclusive (the “Class...
Oct 26, 2022 10:05 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulgent Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - FLGT
NEW YORK, Oct. 26, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT) and certain of its officers. The class action, filed in the United States District Court for the Central District of California, and docketed under 22-cv-06764, is on behalf of a class of all persons and entities who purchased the publicly traded securities of Fulgent securities between March 22, 2019 and August 4, 2022, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' v
Oct 26, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Palantir Technologies, Inc. (NYSE: PLTR), Fulgent Genetics, Inc. (NASDAQ: FLGT),...
Oct 26, 2022 02:00 pm ET
SHAREHOLDER DEADLINE ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. With Losses of $200,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 26, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Oct 26, 2022 01:00 pm ET
DEADLINE ALERT for FLGT, YSG, BCS, OLO: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 26, 2022 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fulgent Genetics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2022 - (NASDAQ: FLGT)
NEW YORK, Oct. 26, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fulgent Genetics, Inc..
Oct 25, 2022 11:00 pm ET
FULGENT GENETICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent Genetics, Inc. - FLGT
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 21, 2022 to file lead plaintiff applications in a securities class action lawsuit against Fulgent Genetics, Inc. (NasdaqGM: FLGT), if they...
Oct 25, 2022 05:03 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact the Firm’s Attorneys, Deadline Approaching in Securities Class Action
Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now. A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations....
Oct 25, 2022 04:03 pm ET
Fulgent Genetics to Participate in Credit Suisse’s 31st Annual Healthcare Conference
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced that members of its management team are scheduled to participate in Credit Suisse’s 31st Annual Healthcare Conference on Tuesday, November 8, 2022.
Oct 25, 2022 05:45 am ET
FLGT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 21, 2022 in the Class Action Filed on Behalf of Fulgent Genetics, Inc. Shareholders
NEW YORK, Oct. 25, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Fulgent Genetics, Inc. (NASDAQ: FLGT) alleging that the Company violated federal securities laws.
Oct 25, 2022 01:45 am ET
FULGENT GENETICS, INC. (NASDAQ: FLGT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Agai
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Oct 24, 2022 05:33 pm ET
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Fulgent Genetics, Inc. (FLGT) Investors and Encourages Investors to Contact the Firm Before November 21, 2
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ:...
Oct 24, 2022 03:32 pm ET
Fulgent Genetics, Inc. (FLGT) Class Action Alert: Contact Robbins LLP if You Lost Money Due to Fulgent Genetics, Inc.'s Misconduct
The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Fulgent Genetics, Inc. (NASDAQ: FLGT) securities between March...
Oct 24, 2022 10:33 am ET
PLTR, FLGT & WBD Class Action Deadlines: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Oct 24, 2022 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fulgent Investors of a Lead Plaintiff Deadline of November 21, 2022
NEW YORK, Oct. 24, 2022 /PRNewswire/ -- Attention Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT) shareholders:
Oct 24, 2022 02:45 am ET
FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. With Losses of $250,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 24, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Oct 22, 2022 08:22 pm ET
FLGT Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Fulgent Genetics, Inc. of Deadline in Securities Fraud Class Action Lawsuit
RADNOR, Pa., Oct. 22, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT). The action charges Fulgent with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Fulgent's materially misleading statements and omissions to the public, Fulgent investors have suffered significant losses.
Oct 22, 2022 04:45 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulgent Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline – FLGT
Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) and certain of its officers.   The class action, filed in the United States District Court for the Central...
Oct 22, 2022 02:12 pm ET
ROSEN, A TOP RANKED FIRM, Encourages Fulgent Genetics, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – FLGT
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, both dates inclusive (the “Class Period”), of the important November...
Oct 21, 2022 10:50 pm ET
FULGENT GENETICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent Genetics, Inc. - FLGT
NEW ORLEANS, Oct. 21, 2022 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 21, 2022 to file lead plaintiff applications in a securities class action lawsuit against Fulgent Genetics, Inc. (NasdaqGM: FLGT), if they purchased the Company's securities between March 22, 2019 and August 4, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the Central District of California.
Oct 21, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Medtronic, Palantir, Fulgent, and Yatsen and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Medtronic PLC (NYSE: MDT), Palantir Technologies, Inc. (NYSE: PLTR), Fulgent...
Oct 21, 2022 01:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming November 21, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fulgent Genetics, Inc. (“Fulgent”...
Oct 21, 2022 11:45 am ET
DEADLINE ALERT for FLGT, YSG, BCS, and OLO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 21, 2022 05:45 am ET
FLGT SHAREHOLDER ALERT: Jakubowitz Law Reminds Fulgent Shareholders of a Lead Plaintiff Deadline of November 21, 2022
NEW YORK, Oct. 21, 2022 /PRNewswire/ --Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Fulgent Genetics, Inc. (NASDAQ: FLGT).
Oct 20, 2022 04:03 pm ET
Fulgent Genetics to Announce Third Quarter 2022 Financial Results on Monday November 7, 2022
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced that it will release its third quarter 2022 financial results after the market closes on Monday November 7, 2022. Management will host a conference call for the investment community the same day at 4:30 PM ET (1:30 PM PT) to discuss the results and answer questions.
Oct 20, 2022 11:00 am ET
DEADLINE ALERT for FLGT, YSG, BCS, OLO: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 20, 2022 05:45 am ET
FLGT LAWSUIT ALERT: Levi & Korsinsky Notifies Fulgent Genetics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Oct. 20, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT) of a class action securities lawsuit.
Oct 19, 2022 10:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Fulgent Genetics, Inc. - FLGT
CEDARHURST, N.Y., Oct. 19, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Fulgent Genetics, Inc. (NasdaqGM: FLGT), if they purchased the Company's securities between March 22, 2019 and August 4, 2022, inclusive (the "Class Period"). Shareholders have until November 21, 2022 to file lead plaintiff applications in the securities class action lawsuit.
Oct 19, 2022 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fulgent Genetics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2022 - (NASDAQ: FLGT)
NEW YORK, Oct. 19, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fulgent Genetics, Inc..
Oct 19, 2022 12:12 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulgent Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - FLGT
NEW YORK, Oct. 19, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT) and certain of its officers. The class action, filed in the United States District Court for the Central District of California, and docketed under 22-cv-06764, is on behalf of a class of all persons and entities who purchased the publicly traded securities of Fulgent securities between March 22, 2019 and August 4, 2022, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' v
Oct 18, 2022 10:54 pm ET
FULGENT GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit A
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 21, 2022 to file lead plaintiff applications in a securities class action lawsuit against...
Oct 18, 2022 07:45 pm ET
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLGT
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, both dates inclusive (the “Class Period”), of the important November 21, 2022 lead plaintiff deadline.
Oct 18, 2022 09:13 am ET
FLGT DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP – Important November 21, 2022 Deadline Reminder in Fulgent Genetics, Inc. Securities Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Fulgent Genetics, Inc....
Oct 18, 2022 01:45 am ET
FULGENT GENETICS, INC. (NASDAQ: FLGT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Agai
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Oct 17, 2022 04:30 pm ET
FLGT FRAUD: Hagens Berman, National Trial Attorneys, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Class Action Pending
Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now. A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations....
Oct 17, 2022 11:00 am ET
FLGT Investors Have Opportunity to Lead Fulgent Genetics, Inc. Securities Fraud Lawsuit
LOS ANGELES, Oct. 17, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT).
Oct 17, 2022 03:30 am ET
SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. With Losses of $250,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 17, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Oct 16, 2022 11:37 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sema4 Holdings Corp. (NASDAQ: SMFR, SMFRW), Medtronic PLC (NYSE: MDT), Palantir...
Oct 14, 2022 10:50 pm ET
FULGENT GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit A
NEW ORLEANS, Oct. 14, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 21, 2022 to file lead plaintiff applications in a securities class action lawsuit against Fulgent Genetics, Inc. (NasdaqGM: FLGT), if they purchased the Company's securities between March 22, 2019 and August 4, 2022, inclusive (the "Class Period").  This action is pending in the United States District Court for the Central District of California.
Oct 14, 2022 09:44 pm ET
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLGT
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, both dates inclusive (the “Class Period”), of the important November...
Oct 14, 2022 08:31 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulgent Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline – FLGT
Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) and certain of its officers. The class action, filed in the United States District Court for the Central...
Oct 14, 2022 03:30 pm ET
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. With Losses of $250,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 14, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Oct 14, 2022 01:00 pm ET
DEADLINE ALERT for FLGT, YSG, BCS, OLO: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 14, 2022 05:45 am ET
FLGT SHAREHOLDER ALERT: Jakubowitz Law Reminds Fulgent Shareholders of a Lead Plaintiff Deadline of November 21, 2022
NEW YORK, Oct. 14, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Fulgent Genetics, Inc. (NASDAQ: FLGT).
Oct 13, 2022 07:46 pm ET
Attention Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Fulgent Genetics, Inc. and Encourages Investors to Contact the F
RADNOR, Pa. , Oct. 13, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT). The action charges Fulgent with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects.  As a result of Fulgent's materially misleading statements and omissions to the public, Fulgent investors have suffered significant losses.
Oct 13, 2022 11:45 am ET
DEADLINE ALERT for FLGT, YSG, BCS, and OLO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 13, 2022 05:45 am ET
FLGT LAWSUIT ALERT: Levi & Korsinsky Notifies Fulgent Genetics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Oct. 13, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT) of a class action securities lawsuit.
Oct 12, 2022 10:56 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Fulgent Genetics, Inc. - FLGT
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Fulgent Genetics, Inc. (NasdaqGM: FLGT), if they purchased the Company’s securities between March 22, 2019 and August 4, 2022, inclusive (the “Class...
Oct 12, 2022 03:25 pm ET
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. With Losses of $250,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 12, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Oct 12, 2022 12:30 pm ET
PLTR, FLGT & WBD Class Action Deadlines: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Oct 12, 2022 12:00 pm ET
Oct 12, 2022 09:38 am ET
SMFR INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Class Action Filed
Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now. A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations....
Oct 12, 2022 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fulgent Genetics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2022 - (NASDAQ: FLGT)
NEW YORK, Oct. 12, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fulgent Genetics, Inc..
Oct 11, 2022 10:51 pm ET
FULGENT GENETICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent Genetics, Inc. - FLGT
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 21, 2022 to file lead plaintiff applications in a securities class action lawsuit against Fulgent Genetics, Inc. (NasdaqGM: FLGT), if they...
Oct 11, 2022 10:35 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sema4 Holdings Corp. (NASDAQ: SMFR, SMFRW), Medtronic PLC (NYSE: MDT), Palantir...
Oct 11, 2022 01:45 am ET
FULGENT GENETICS, INC. (NASDAQ: FLGT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Agai
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Oct 10, 2022 11:53 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulgent Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - FLGT
NEW YORK, Oct. 10, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT) and certain of its officers. The class action, filed in the United States District Court for the Central District of California, and docketed under 22-cv-06764, is on behalf of a class of all persons and entities who purchased the publicly traded securities of Fulgent securities between March 22, 2019 and August 4, 2022, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' v
Oct 10, 2022 04:00 pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. With Losses of $250,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 10, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Oct 10, 2022 12:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming November 21, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fulgent Genetics, Inc. (“Fulgent”...
Oct 09, 2022 09:22 pm ET
FLGT Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Fulgent Genetics, Inc. of Deadline in Securities Fraud Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Fulgent Genetics, Inc....
Oct 07, 2022 10:50 pm ET
FULGENT GENETICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent Genetics, Inc. - FLGT
NEW ORLEANS, Oct. 7, 2022 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 21, 2022 to file lead plaintiff applications in a securities class action lawsuit against Fulgent Genetics, Inc. (NasdaqGM: FLGT), if they purchased the Company's securities between March 22, 2019 and August 4, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the Central District of California.
Oct 07, 2022 12:58 pm ET
DEADLINE ALERT for FLGT, YSG, BCS, OLO: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 07, 2022 05:45 am ET
FLGT SHAREHOLDER ALERT: Jakubowitz Law Reminds Fulgent Shareholders of a Lead Plaintiff Deadline of November 21, 2022
NEW YORK, Oct. 7, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Fulgent Genetics, Inc. (NASDAQ: FLGT).
Oct 06, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sema4 Holdings Corp. (NASDAQ: SMFR, SMFRW), Medtronic PLC (NYSE: MDT), Palantir...
Oct 06, 2022 04:15 pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. With Losses of $250,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 6, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Oct 06, 2022 03:58 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulgent Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline – FLGT
Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) and certain of its officers. The class action, filed in the United States District Court for the Central...
Oct 06, 2022 05:45 am ET
FLGT LAWSUIT ALERT: Levi & Korsinsky Notifies Fulgent Genetics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Oct. 6, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT) of a class action securities lawsuit.
Oct 05, 2022 10:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Fulgent Genetics, Inc. - FLGT
CEDARHURST, N.Y., Oct. 5, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Fulgent Genetics, Inc. (NasdaqGM: FLGT), if they purchased the Company's securities between March 22, 2019 and August 4, 2022, inclusive (the "Class Period"). Shareholders have until November 21, 2022 to file lead plaintiff applications in the securities class action lawsuit.
Oct 04, 2022 10:54 pm ET
FULGENT GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit A
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 21, 2022 to file lead plaintiff applications in a securities class action lawsuit against...
Oct 04, 2022 09:30 pm ET
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. With Losses of $250,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / October 4, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Oct 04, 2022 07:20 pm ET
Fulgent Genetics, Inc. Shareholder Notice: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in Class Action Against Fulgent Genetics, Inc. (FLGT)
The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Fulgent Genetics, Inc. (NASDAQ: FLGT) securities between March...
Oct 04, 2022 05:44 pm ET
Kessler Topaz Meltzer & Check, LLP Reminds Fulgent Genetics, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit
RADNOR, Pa., Oct. 4, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT). The action charges Fulgent with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects.  As a result of Fulgent's materially misleading statements and omissions to the public, Fulgent investors have suffered significant losses.
Oct 04, 2022 05:45 am ET
FLGT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 21, 2022 in the Class Action Filed on Behalf of Fulgent Genetics, Inc. Shareholders
NEW YORK, Oct. 4, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Fulgent Genetics, Inc. (NASDAQ: FLGT) alleging that the Company violated federal securities laws.
Oct 04, 2022 04:00 am ET
FULGENT GENETICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Central
Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Central District of California against Fulgent Genetics, Inc. (“Fulgent” or the “Company”)...
Oct 04, 2022 01:45 am ET
FULGENT GENETICS, INC. (NASDAQ: FLGT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Agai
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Oct 03, 2022 07:30 pm ET
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLGT
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, both dates inclusive (the “Class Period”), of the important November...
Oct 03, 2022 12:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming November 21, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fulgent Genetics, Inc. (“Fulgent”...
Oct 03, 2022 11:53 am ET
FLGT ALERT: Hagens Berman, National Trial Attorneys, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact the Firm’s Attorneys, Securities Class Action Filed
Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now. A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations....
Oct 03, 2022 11:46 am ET
DEADLINE ALERT for FLGT, YSG, BCS, and OLO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 03, 2022 10:10 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulgent Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - FLGT
NEW YORK, Oct. 3, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT) and certain of its officers.  The class action, filed in the United States District Court for the Central District of California, and docketed under 22-cv-06764, is on behalf of a class of all persons and entities who purchased the publicly traded securities of Fulgent securities between March 22, 2019 and August 4, 2022, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' v
Oct 03, 2022 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fulgent Investors of a Lead Plaintiff Deadline of November 21, 2022
NEW YORK, Oct. 3, 2022 /PRNewswire/ -- Attention Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT) shareholders:

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.